REG - Kanabo Group PLC - Grant of Options

KanaboAnnouncement

31/12/2021 10:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211231:nRSe1890Xa&default-theme=true

RNS Number : 1890X  Kanabo Group PLC  31 December 2021

Kanabo Group Plc

("Kanabo" or the "Company")

Grant of Options

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis company that
focuses on developing and commercialising cannabis-derived products for
medical patients and wellness CBD consumers announces the grant of options
over a total of 3,150,000 shares to certain employees, including General
Manager, Michal Ben Moshe, pursuant to their terms of employment.

 

 

 Name             No. of Options  Vested options as of today  Option Exercise Price  Vesting Period for non-vested options
 Michal Ben       2,025,000       506,250                     16.5p                  Options shall vest in 12 equal tranches every three months over a 3-year

                                                                                   period.
 Moshe )PDMR)

 Other employees  1,125,000       -                           16.5p                  Options shall vest over a 4-year period, with 25% vesting at the end of the

                      first 12-months ("the Initial Vesting") and the remaining 75% vesting in 12
                                                                                     equal tranches every three months following the Initial Vesting.

 

For further information, please visit http://www.kanabogroup.com/ or contact
the following:

 Kanabo Group Plc
 Avihu Tamir, CEO                                       Via Vox Markets
 Peterhouse Capital Ltd
 Eran Zucker (Financial Adviser)                        Tel: +44 (0)20 7469 0930
 Lucy Williams / Charles Goodfellow (Corporate Broker)  Tel: +44 (0)20 7469 0930
 Vox Markets (Investor Relations)
 Kat Perez                                              KanaboGroup@voxmarkets.co.uk

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry
to improve the well-being of millions of people around the world by providing
a better alternative to the smoking of medicinal cannabis flowers. Kanabo,
which was the first medicinal cannabis company to IPO on London Stock
Exchange, has a focus on the distribution of cannabis-derived products for
medical patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality cannabis extract
formulas, innovative medical-grade vaporizers, and various non-smoking
consumption solutions. Kanabo sells a range of medical cannabis products and
wellness CBD products in the Primary Markets, including its VapePod, which
delivers a metered dose with every inhalation.

The Notification of Dealing Form provided in accordance with the requirements
of the Market Abuse Regulation in relation to the transaction listed above is
set out below.

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Michal Ben Moshe

 

 2    Reason for the notification

 a)   Position/status                                              Manager

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Kanabo Group Plc

 b)   LEI                                                          213800XPJFSNWJIYKN52

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares

      Identification code                                          GB00BYQCS703

 b)   Nature of the transaction                                    Share Options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     16.5p             2,025,000

 d)   Aggregated information

      - Aggregated volume                                          N/A

      - Price                                                      N/A

 e)   Date of the transaction                                      24.10.2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHDKDBPCBDKCBN